GLUTATHIONE

GLUTATHIONE was reported 1725 times

GLUTATHIONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEAVY METAL INCREASED 2 0.0909
1 ACQUIRED ANTITHROMBIN III DEFICIENCY 1 0.0714
2 EOSINOPHILIC PNEUMONIA CHRONIC 15 0.0505
3 GRAFT VERSUS HOST DISEASE IN INTESTINE 5 0.0385
4 ANAL EROSION 4 0.0364
5 CHRONIC DISEASE 9 0.0353
6 METAL POISONING 18 0.0310
7 ALBUMIN URINE 1 0.0227
8 BILE ACIDS INCREASED 4 0.0226
9 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 4 0.0226
10 INJECTION SITE FIBROSIS 2 0.0171
11 ADMINISTRATION SITE NODULE 1 0.0167
12 ANAMNESTIC REACTION 1 0.0161
13 MULTIPLE CHEMICAL SENSITIVITY 2 0.0150
14 INCISION SITE PAIN 17 0.0145
15 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 2 0.0135
16 RED BLOOD CELLS URINE POSITIVE 13 0.0134
17 ACID-BASE BALANCE DISORDER MIXED 1 0.0133
18 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 1 0.0127
19 BETA 2 MICROGLOBULIN INCREASED 3 0.0115
20 BLOOD CHOLINESTERASE DECREASED 3 0.0109
21 MONONEUROPATHY 2 0.0096
22 OESOPHAGEAL FISTULA 3 0.0094
23 EXPOSURE TO FUNGUS 2 0.0093
24 ACID BASE BALANCE ABNORMAL 2 0.0089
25 URETHRAL DISORDER 4 0.0085
26 CHEST WALL MASS 2 0.0077
27 SWEAT GLAND DISORDER 3 0.0071
28 ENTHESOPATHY 11 0.0070
29 HYPOPROTEINAEMIA 13 0.0068
30 CHRONIC HEPATITIS B 2 0.0063
31 LUNG OPACITY 16 0.0061
32 INSULIN AUTOIMMUNE SYNDROME 2 0.0056
33 OESOPHAGEAL MOTILITY DISORDER 2 0.0056
34 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
35 PRODUCT COMPOUNDING QUALITY ISSUE 2 0.0055
36 LID SULCUS DEEPENED 2 0.0054
37 MYOCARDIAL INJURY 6 0.0053
38 ALBUMIN URINE PRESENT 2 0.0053
39 BILIARY TRACT INFECTION 3 0.0048
40 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
41 ALANINE AMINOTRANSFERASE 1 0.0045
42 INFUSION SITE SCAR 2 0.0045
43 APPENDICEAL ABSCESS 1 0.0041
44 ENCEPHALITIS HERPES 2 0.0040
45 HYPERSPLENISM 2 0.0040
46 CARDIAC INFECTION 3 0.0040
47 THROAT CLEARING 15 0.0040
48 URETERIC STENOSIS 3 0.0037
49 ANTITHROMBIN III DECREASED 1 0.0037
50 HYPOALBUMINAEMIA 28 0.0036
51 MAST CELL ACTIVATION SYNDROME 5 0.0036
52 BILIRUBIN CONJUGATED INCREASED 8 0.0034
53 HYPERURICAEMIA 14 0.0034
54 SACRAL PAIN 2 0.0033
55 ORAL MUCOSA EROSION 4 0.0033
56 GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0032
57 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
58 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
59 INFECTIOUS PERITONITIS 2 0.0029
60 HEPATIC FUNCTION ABNORMAL 109 0.0029
61 ANASTOMOTIC LEAK 2 0.0029
62 DERMATITIS DIAPER 2 0.0028
63 THYROXINE INCREASED 2 0.0028
64 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
65 NEUTROPHIL COUNT INCREASED 28 0.0027
66 LYMPHOCYTE COUNT DECREASED 48 0.0027
67 ALKALOSIS 1 0.0026
68 CAUDA EQUINA SYNDROME 2 0.0026
69 ADRENAL GLAND CANCER 1 0.0026
70 HYPOCHLORAEMIA 3 0.0026
71 BLOOD ALBUMIN DECREASED 20 0.0025
72 PLACENTAL INSUFFICIENCY 2 0.0025
73 RESPIRATORY ALKALOSIS 4 0.0025
74 DYSBIOSIS 2 0.0024
75 POST-ACUTE COVID-19 SYNDROME 3 0.0024
76 NASAL PRURITUS 3 0.0024
77 MYOCARDIAL NECROSIS MARKER INCREASED 4 0.0024
78 INFECTED BITE 2 0.0024
79 BLOOD ALBUMIN INCREASED 2 0.0022
80 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
81 SALIVA ALTERED 2 0.0022
82 HYPERPLASIA 2 0.0022
83 DRUG-INDUCED LIVER INJURY 69 0.0022
84 ALLERGY TO PLANTS 1 0.0022
85 RENAL ARTERY STENOSIS 3 0.0022
86 CHRONIC FATIGUE SYNDROME 3 0.0022
87 EOSINOPHIL COUNT INCREASED 17 0.0020
88 HYPOPHOSPHATAEMIA 15 0.0020
89 CONSCIOUSNESS FLUCTUATING 2 0.0019
90 HEPATITIS E 3 0.0019
91 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
92 ALBUMINURIA 1 0.0019
93 PNEUMONIA BACTERIAL 17 0.0019
94 KIDNEY ENLARGEMENT 2 0.0018
95 BOWEL MOVEMENT IRREGULARITY 14 0.0018
96 BLOOD FIBRINOGEN DECREASED 2 0.0018
97 SICK SINUS SYNDROME 2 0.0017
98 DEFAECATION URGENCY 12 0.0017
99 PROCALCITONIN INCREASED 2 0.0017
100 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
101 ADENOMYOSIS 1 0.0017
102 SPUTUM DISCOLOURED 16 0.0017
103 AGRAPHIA 1 0.0017
104 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
105 HAEMATOLOGICAL INFECTION 4 0.0016
106 PROTEIN URINE PRESENT 8 0.0016
107 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
108 INFUSION SITE IRRITATION 2 0.0016
109 HYPOCALCAEMIA 29 0.0015
110 DRUG CLEARANCE DECREASED 2 0.0015
111 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
112 FULL BLOOD COUNT ABNORMAL 16 0.0015
113 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
114 BREAST DISORDER 3 0.0015
115 URETERIC OBSTRUCTION 2 0.0015
116 LIVER INJURY 36 0.0015
117 EFFUSION 2 0.0015
118 KIDNEY TRANSPLANT REJECTION 7 0.0015
119 APPLICATION SITE INFLAMMATION 2 0.0014
120 PRE-EXISTING CONDITION IMPROVED 9 0.0014
121 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
122 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
123 FIBRIN D DIMER INCREASED 5 0.0014
124 RADIATION PNEUMONITIS 3 0.0014
125 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
126 ANTIBODY TEST ABNORMAL 1 0.0014
127 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
128 NEUTROPHIL COUNT DECREASED 56 0.0014
129 MYELOSUPPRESSION 49 0.0014
130 APPETITE DISORDER 9 0.0014
131 PROTEIN TOTAL DECREASED 5 0.0013
132 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
133 BLOOD UREA INCREASED 22 0.0013
134 GENITAL HERPES 2 0.0013
135 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
136 FLAT AFFECT 3 0.0013
137 BREATH ODOUR 3 0.0012
138 LYMPHOCYTE COUNT INCREASED 4 0.0012
139 INJECTION RELATED REACTION 2 0.0012
140 DEVICE INFUSION ISSUE 3 0.0012
141 ALANINE AMINOTRANSFERASE INCREASED 73 0.0012
142 TENDON PAIN 9 0.0012
143 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
144 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
145 TENDONITIS 18 0.0012
146 HYPERTRANSAMINASAEMIA 8 0.0011
147 MASTECTOMY 2 0.0011
148 BLOOD BILIRUBIN INCREASED 30 0.0011
149 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
150 SOFT TISSUE INFECTION 2 0.0011
151 SINUS NODE DYSFUNCTION 2 0.0011
152 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
153 LOBAR PNEUMONIA 2 0.0011
154 PUPILLARY REFLEX IMPAIRED 2 0.0011
155 GRANULOCYTE COUNT DECREASED 2 0.0011
156 LYMPH NODE PAIN 2 0.0011
157 PULMONARY MASS 16 0.0011
158 TUMOUR HAEMORRHAGE 3 0.0011
159 ACTINOMYCOSIS 1 0.0010
160 ADRENAL DISORDER 2 0.0010
161 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
162 HYPERTRIGLYCERIDAEMIA 6 0.0010
163 MULTI-ORGAN DISORDER 2 0.0010
164 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
165 PAPULE 7 0.0010
166 DEVICE RELATED SEPSIS 2 0.0010
167 IMMUNE-MEDIATED HEPATITIS 2 0.0010
168 HYPOKALAEMIA 45 0.0010
169 VENOUS THROMBOSIS LIMB 2 0.0010
170 CAPILLARY LEAK SYNDROME 2 0.0010
171 LUNG INFECTION 15 0.0010
172 LUNG ABSCESS 2 0.0010
173 INFUSION SITE PRURITUS 3 0.0009
174 HEPATIC NEOPLASM MALIGNANT 2 0.0009
175 TRANSAMINASES INCREASED 21 0.0009
176 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 16 0.0009
177 ALLERGY TO ANIMAL 1 0.0009
178 PULMONARY TUBERCULOSIS 4 0.0009
179 STUPOR 3 0.0009
180 HYPOMAGNESAEMIA 13 0.0009
181 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
182 CLOSTRIDIUM TEST POSITIVE 2 0.0009
183 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
184 LYME DISEASE 3 0.0009
185 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
186 BACTERIAL TEST POSITIVE 2 0.0009
187 PLATELET COUNT DECREASED 95 0.0009
188 METASTASES TO LYMPH NODES 6 0.0009
189 BONE MARROW FAILURE 18 0.0009
190 GASTRIC POLYPS 2 0.0009
191 HEPATIC CYST 3 0.0009
192 ADMINISTRATION SITE PAIN 1 0.0009
193 ELECTROLYTE IMBALANCE 10 0.0009
194 JAUNDICE CHOLESTATIC 3 0.0008
195 LACUNAR INFARCTION 2 0.0008
196 ENTEROCOCCAL INFECTION 4 0.0008
197 FOOD INTOLERANCE 3 0.0008
198 WHITE BLOOD CELL COUNT INCREASED 31 0.0008
199 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
200 HEPATIC FAILURE 24 0.0008
201 INFUSION SITE SWELLING 5 0.0008
202 AUTOIMMUNE THYROIDITIS 3 0.0008
203 FACE INJURY 3 0.0008
204 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
205 ABDOMINAL INFECTION 2 0.0008
206 BLOOD CHLORIDE DECREASED 2 0.0008
207 LIPOMA 2 0.0008
208 ACTINIC KERATOSIS 2 0.0008
209 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
210 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
211 YAWNING 2 0.0007
212 CANDIDIASIS 3 0.0007
213 POST-TRAUMATIC STRESS DISORDER 5 0.0007
214 CYSTITIS HAEMORRHAGIC 3 0.0007
215 BREAST SWELLING 2 0.0007
216 WEIGHT BEARING DIFFICULTY 2 0.0007
217 WHITE BLOOD CELL COUNT DECREASED 80 0.0007
218 CLUMSINESS 2 0.0007
219 AGORAPHOBIA 1 0.0007
220 ORAL FUNGAL INFECTION 2 0.0007
221 TYPE IV HYPERSENSITIVITY REACTION 2 0.0007
222 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
223 C-REACTIVE PROTEIN INCREASED 26 0.0007
224 MUSCLE ATROPHY 9 0.0007
225 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
226 MUSCLE FATIGUE 3 0.0007
227 TONGUE DISCOMFORT 3 0.0007
228 CHOLECYSTITIS ACUTE 4 0.0007
229 OCULAR ICTERUS 3 0.0007
230 ADENOVIRUS INFECTION 2 0.0007
231 HEPATITIS FULMINANT 2 0.0007
232 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
233 INFUSION SITE REACTION 2 0.0007
234 BRAIN HERNIATION 2 0.0007
235 HYPERLIPIDAEMIA 8 0.0007
236 GASTROINTESTINAL INFECTION 6 0.0007
237 HEPATITIS B 4 0.0007
238 COAGULOPATHY 11 0.0007
239 AGE-RELATED MACULAR DEGENERATION 1 0.0007
240 IRITIS 2 0.0007
241 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
242 DUODENITIS 2 0.0007
243 LOCALISED OEDEMA 3 0.0006
244 FOOD ALLERGY 5 0.0006
245 BRAIN DEATH 2 0.0006
246 HEPATIC ENCEPHALOPATHY 6 0.0006
247 YELLOW SKIN 3 0.0006
248 BLOOD BLISTER 2 0.0006
249 SEASONAL ALLERGY 9 0.0006
250 HYPOVOLAEMIC SHOCK 3 0.0006
251 CUSHINGOID 2 0.0006
252 ACUTE LEUKAEMIA 1 0.0006
253 AUTOIMMUNE DISORDER 6 0.0006
254 BACTERIAL SEPSIS 2 0.0006
255 ABDOMINAL TENDERNESS 3 0.0006
256 HYPERNATRAEMIA 3 0.0006
257 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
258 HYPERAMMONAEMIA 3 0.0006
259 FLUID INTAKE REDUCED 3 0.0006
260 ANXIETY DISORDER 2 0.0006
261 PLANTAR FASCIITIS 2 0.0006
262 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
263 INFUSION SITE ERYTHEMA 5 0.0006
264 BK VIRUS INFECTION 2 0.0006
265 CHOLECYSTITIS 7 0.0006
266 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
267 HYPERBILIRUBINAEMIA 6 0.0006
268 ALOPECIA AREATA 1 0.0006
269 SERUM FERRITIN INCREASED 3 0.0006
270 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
271 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
272 LYMPHADENOPATHY 20 0.0006
273 FOOD POISONING 3 0.0006
274 BRUXISM 3 0.0006
275 DEVICE KINK 2 0.0005
276 BLOOD PHOSPHORUS DECREASED 2 0.0005
277 STOMATITIS 33 0.0005
278 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
279 HEPATOTOXICITY 12 0.0005
280 HYPERACUSIS 2 0.0005
281 CHRONIC SINUSITIS 2 0.0005
282 PARANASAL SINUS DISCOMFORT 2 0.0005
283 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
284 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
285 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
286 BLOOD URIC ACID INCREASED 3 0.0005
287 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
288 ANAEMIA 98 0.0005
289 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
290 CERVIX CARCINOMA 2 0.0005
291 PNEUMONIA FUNGAL 2 0.0005
292 POLYDIPSIA 2 0.0005
293 LIGAMENT SPRAIN 5 0.0005
294 BACTERAEMIA 6 0.0005
295 NASAL DISCOMFORT 4 0.0005
296 ANORECTAL DISORDER 1 0.0005
297 OBSTRUCTION 2 0.0005
298 SALIVARY HYPERSECRETION 5 0.0005
299 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
300 ORGAN FAILURE 2 0.0005
301 VITAMIN B12 DEFICIENCY 2 0.0005
302 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
303 SINUS TACHYCARDIA 7 0.0005
304 LARYNGEAL OEDEMA 3 0.0005
305 INFUSION SITE EXTRAVASATION 3 0.0005
306 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
307 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
308 SHOULDER OPERATION 2 0.0005
309 PRODUCT DISPENSING ISSUE 2 0.0005
310 MYOPATHY 4 0.0005
311 HEPATITIS ACUTE 3 0.0005
312 PLATELET COUNT INCREASED 6 0.0005
313 TENDON DISORDER 3 0.0005
314 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
315 URINE OUTPUT DECREASED 4 0.0005
316 DEVICE RELATED INFECTION 7 0.0005
317 CORONAVIRUS INFECTION 3 0.0005
318 GINGIVAL SWELLING 2 0.0005
319 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
320 BLOOD CREATINE INCREASED 2 0.0005
321 CARDIAC FAILURE ACUTE 3 0.0004
322 ORAL PAIN 10 0.0004
323 SKIN INFECTION 5 0.0004
324 MENINGITIS ASEPTIC 2 0.0004
325 SUSPECTED OFF LABEL USE 2 0.0004
326 HAEMOGLOBIN INCREASED 2 0.0004
327 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
328 METASTASES TO LUNG 5 0.0004
329 FORMICATION 3 0.0004
330 SPLENOMEGALY 5 0.0004
331 VAGINAL INFECTION 2 0.0004
332 LEUKOPENIA 21 0.0004
333 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
334 WRIST FRACTURE 5 0.0004
335 TUMOUR MARKER INCREASED 2 0.0004
336 PARAESTHESIA ORAL 6 0.0004
337 NEURALGIA 10 0.0004
338 HORMONE LEVEL ABNORMAL 2 0.0004
339 JAUNDICE 11 0.0004
340 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
341 ARTHROPOD BITE 3 0.0004
342 PNEUMONITIS 11 0.0004
343 INFLAMMATORY MARKER INCREASED 2 0.0004
344 HYDRONEPHROSIS 3 0.0004
345 DERMATITIS ALLERGIC 5 0.0004
346 TASTE DISORDER 8 0.0004
347 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
348 CHEST DISCOMFORT 40 0.0004
349 INCREASED UPPER AIRWAY SECRETION 2 0.0004
350 THYROID DISORDER 6 0.0004
351 AORTIC ARTERIOSCLEROSIS 1 0.0004
352 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
353 TRISMUS 2 0.0004
354 RED BLOOD CELL COUNT DECREASED 11 0.0004
355 RESPIRATORY TRACT INFECTION 10 0.0004
356 PETECHIAE 4 0.0004
357 MULTIPLE ALLERGIES 3 0.0004
358 RESTLESSNESS 14 0.0004
359 MUCOSAL INFLAMMATION 10 0.0004
360 FOOD CRAVING 2 0.0004
361 BLOOD LACTIC ACID INCREASED 2 0.0004
362 MOUTH ULCERATION 8 0.0004
363 LOW BIRTH WEIGHT BABY 3 0.0004
364 PRODUCTIVE COUGH 18 0.0004
365 NYSTAGMUS 2 0.0004
366 AGRANULOCYTOSIS 7 0.0004
367 ANIMAL BITE 1 0.0004
368 ALCOHOL POISONING 1 0.0004
369 ABDOMINAL MASS 1 0.0004
370 DECREASED ACTIVITY 4 0.0004
371 PROTEINURIA 7 0.0004
372 IMPAIRED GASTRIC EMPTYING 5 0.0004
373 APPLICATION SITE HAEMORRHAGE 1 0.0004
374 ACUTE HEPATIC FAILURE 5 0.0004
375 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
376 ESCHERICHIA INFECTION 3 0.0004
377 ECZEMA 19 0.0004
378 CHOKING SENSATION 2 0.0004
379 INTRACRANIAL PRESSURE INCREASED 2 0.0004
380 MALNUTRITION 4 0.0004
381 ANAL HAEMORRHAGE 1 0.0004
382 MACULAR OEDEMA 2 0.0004
383 PANCREATITIS ACUTE 8 0.0004
384 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
385 WHEEZING 21 0.0004
386 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
387 HEPATOCELLULAR INJURY 5 0.0004
388 GRANULOCYTOPENIA 2 0.0004
389 PSEUDOMONAS INFECTION 3 0.0003
390 MYOCARDITIS 4 0.0003
391 HERPES VIRUS INFECTION 2 0.0003
392 NEUROPATHY PERIPHERAL 33 0.0003
393 LUNG DISORDER 17 0.0003
394 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
395 LIVER FUNCTION TEST ABNORMAL 10 0.0003
396 DYSPHONIA 20 0.0003
397 HEAD DISCOMFORT 6 0.0003
398 DRUG ERUPTION 6 0.0003
399 PERITONITIS 7 0.0003
400 RESPIRATORY RATE INCREASED 3 0.0003
401 BLOOD CREATININE INCREASED 22 0.0003
402 FACIAL PAIN 3 0.0003
403 RHABDOMYOLYSIS 14 0.0003
404 HAEMOLYTIC ANAEMIA 3 0.0003
405 PROTHROMBIN TIME PROLONGED 2 0.0003
406 DERMATITIS 7 0.0003
407 BLOOD PRESSURE FLUCTUATION 8 0.0003
408 ACNE CYSTIC 1 0.0003
409 FEBRILE NEUTROPENIA 22 0.0003
410 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
411 TENDON RUPTURE 4 0.0003
412 COGNITIVE DISORDER 15 0.0003
413 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
414 BRAIN FOG 5 0.0003
415 ABDOMINAL DISTENSION 33 0.0003
416 FEELING JITTERY 6 0.0003
417 PREMATURE DELIVERY 5 0.0003
418 THROMBOCYTOPENIA 35 0.0003
419 HAEMOGLOBIN DECREASED 32 0.0003
420 SINUS BRADYCARDIA 3 0.0003
421 RENAL IMPAIRMENT 26 0.0003
422 BACK DISORDER 5 0.0003
423 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
424 ASPERGILLUS INFECTION 2 0.0003
425 METASTASES TO BONE 5 0.0003
426 GASTROINTESTINAL DISORDER 27 0.0003
427 OVARIAN CYST 3 0.0003
428 MENINGITIS 2 0.0003
429 QUALITY OF LIFE DECREASED 4 0.0003
430 EMPHYSEMA 3 0.0003
431 PRODUCT LABEL ISSUE 2 0.0003
432 TOOTH ABSCESS 3 0.0003
433 APPLICATION SITE DRYNESS 1 0.0003
434 TACHYPNOEA 4 0.0003
435 BODY TEMPERATURE INCREASED 6 0.0003
436 LIVER DISORDER 13 0.0003
437 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
438 PERIPHERAL COLDNESS 4 0.0003
439 TEMPERATURE INTOLERANCE 3 0.0003
440 ONYCHOCLASIS 2 0.0003
441 RESPIRATION ABNORMAL 2 0.0003
442 POOR VENOUS ACCESS 3 0.0003
443 DROOLING 2 0.0003
444 VENTRICULAR EXTRASYSTOLES 3 0.0003
445 LARGE INTESTINE POLYP 2 0.0003
446 EXTRASYSTOLES 2 0.0003
447 RIGHT VENTRICULAR FAILURE 2 0.0003
448 FLUSHING 29 0.0003
449 INJECTION SITE DISCOMFORT 3 0.0003
450 LYMPHOPENIA 4 0.0003
451 METABOLIC ACIDOSIS 9 0.0003
452 RETCHING 6 0.0003
453 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
454 HYPERTHYROIDISM 4 0.0003
455 FAECES SOFT 2 0.0003
456 RASH PUSTULAR 2 0.0003
457 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
458 WOUND INFECTION 3 0.0003
459 UTERINE LEIOMYOMA 2 0.0003
460 MOUTH HAEMORRHAGE 2 0.0003
461 MELAENA 6 0.0003
462 AMYLASE INCREASED 1 0.0003
463 HEPATIC STEATOSIS 5 0.0003
464 HAEMORRHAGE INTRACRANIAL 4 0.0003
465 INTESTINAL PERFORATION 3 0.0003
466 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
467 EYE INFECTION 3 0.0003
468 ASTHMA 30 0.0003
469 INTESTINAL OBSTRUCTION 10 0.0003
470 PAROSMIA 2 0.0003
471 APHASIA 8 0.0003
472 IMPAIRED DRIVING ABILITY 3 0.0003
473 BLOOD URINE PRESENT 5 0.0003
474 EPILEPSY 8 0.0003
475 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
476 RESPIRATORY FAILURE 19 0.0003
477 MUSCLE TWITCHING 6 0.0003
478 PERICARDIAL EFFUSION 6 0.0003
479 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
480 APHTHOUS ULCER 2 0.0003
481 EJECTION FRACTION DECREASED 4 0.0003
482 ACUTE MYELOID LEUKAEMIA 4 0.0003
483 BASAL CELL CARCINOMA 4 0.0003
484 ORAL HERPES 5 0.0003
485 PULMONARY HAEMORRHAGE 2 0.0003
486 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
487 PNEUMOTHORAX 4 0.0003
488 RENAL CYST 2 0.0003
489 FEELING COLD 7 0.0003
490 ATRIAL FLUTTER 2 0.0003
491 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
492 HEPATIC ENZYME INCREASED 17 0.0002
493 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
494 PYREXIA 86 0.0002
495 NIGHT SWEATS 8 0.0002
496 ADRENAL INSUFFICIENCY 3 0.0002
497 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
498 HYPERGLYCAEMIA 9 0.0002
499 MUSCLE DISORDER 2 0.0002
500 FIBROMYALGIA 6 0.0002
501 SHOCK HAEMORRHAGIC 2 0.0002
502 ABNORMAL FAECES 2 0.0002
503 HICCUPS 2 0.0002
504 ABNORMAL WEIGHT GAIN 3 0.0002
505 APPLICATION SITE EXFOLIATION 1 0.0002
506 PHARYNGITIS 3 0.0002
507 MENSTRUAL DISORDER 2 0.0002
508 ACUTE CORONARY SYNDROME 2 0.0002
509 INFUSION RELATED REACTION 16 0.0002
510 HAIR COLOUR CHANGES 3 0.0002
511 VIRAL INFECTION 8 0.0002
512 OEDEMA 13 0.0002
513 BRAIN OEDEMA 3 0.0002
514 SKIN PLAQUE 2 0.0002
515 CANDIDA INFECTION 4 0.0002
516 CARDIAC FAILURE 19 0.0002
517 AORTIC VALVE INCOMPETENCE 1 0.0002
518 MYDRIASIS 3 0.0002
519 SCAR 4 0.0002
520 ROTATOR CUFF SYNDROME 3 0.0002
521 ALCOHOLISM 1 0.0002
522 PRODUCT CONTAINER ISSUE 2 0.0002
523 INFUSION SITE PAIN 3 0.0002
524 MUSCULOSKELETAL DISCOMFORT 4 0.0002
525 CHEST PAIN 43 0.0002
526 PARANOIA 4 0.0002
527 INJECTION SITE INDURATION 3 0.0002
528 DIPLOPIA 6 0.0002
529 COMA 11 0.0002
530 HYSTERECTOMY 2 0.0002
531 DELIRIUM 8 0.0002
532 SKIN SWELLING 2 0.0002
533 PLEURAL EFFUSION 14 0.0002
534 MUSCULOSKELETAL STIFFNESS 20 0.0002
535 NEUROTOXICITY 4 0.0002
536 BLOOD CALCIUM INCREASED 2 0.0002
537 NEUTROPENIA 31 0.0002
538 GROIN PAIN 2 0.0002
539 HYPOXIA 8 0.0002
540 COLD SWEAT 4 0.0002
541 PNEUMONIA 73 0.0002
542 SINUSITIS 23 0.0002
543 NERVOUS SYSTEM DISORDER 7 0.0002
544 DISTURBANCE IN ATTENTION 12 0.0002
545 THERAPY NON-RESPONDER 10 0.0002
546 ANAL INCONTINENCE 2 0.0002
547 SINUS CONGESTION 3 0.0002
548 CHILLS 26 0.0002
549 LEUKOCYTOSIS 4 0.0002
550 OPTIC NEURITIS 2 0.0002
551 CYSTITIS 7 0.0002
552 PANIC ATTACK 8 0.0002
553 HYPOTHYROIDISM 7 0.0002
554 SKIN DISCOLOURATION 10 0.0002
555 INCREASED TENDENCY TO BRUISE 2 0.0002
556 CONDITION AGGRAVATED 66 0.0002
557 NERVE COMPRESSION 2 0.0002
558 SEIZURE 25 0.0002
559 PRODUCT DISTRIBUTION ISSUE 2 0.0002
560 COORDINATION ABNORMAL 3 0.0002
561 ERYTHEMA MULTIFORME 2 0.0002
562 APPENDICITIS 2 0.0002
563 ABORTION INDUCED 2 0.0002
564 GASTRIC ULCER 4 0.0002
565 RECALLED PRODUCT ADMINISTERED 2 0.0002
566 HYPERHIDROSIS 27 0.0002
567 MYELODYSPLASTIC SYNDROME 3 0.0002
568 MENTAL DISORDER 9 0.0002
569 INTERSTITIAL LUNG DISEASE 10 0.0002
570 EAR PAIN 4 0.0002
571 HAEMORRHOIDS 4 0.0002
572 PLASMA CELL MYELOMA 8 0.0002
573 CEREBRAL INFARCTION 5 0.0002
574 HAEMATURIA 7 0.0002
575 ASCITES 6 0.0002
576 COELIAC DISEASE 2 0.0002
577 HEPATOMEGALY 2 0.0002
578 VITREOUS FLOATERS 2 0.0002
579 BLADDER DISORDER 2 0.0002
580 BLOOD PRESSURE ABNORMAL 4 0.0002
581 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
582 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
583 MYALGIA 34 0.0002
584 FULL BLOOD COUNT DECREASED 4 0.0002
585 BLOOD COUNT ABNORMAL 3 0.0002
586 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
587 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
588 DRY THROAT 2 0.0002
589 MOTOR DYSFUNCTION 2 0.0002
590 INSURANCE ISSUE 3 0.0002
591 AMMONIA INCREASED 1 0.0002
592 HEPATITIS 5 0.0002
593 EAR DISCOMFORT 2 0.0002
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
595 ILLNESS 20 0.0002
596 UNRESPONSIVE TO STIMULI 5 0.0002
597 INFECTION 28 0.0002
598 BLOOD CHOLESTEROL INCREASED 9 0.0002
599 THERAPY PARTIAL RESPONDER 3 0.0002
600 WEIGHT FLUCTUATION 2 0.0002
601 DYSURIA 7 0.0002
602 GASTRITIS 5 0.0002
603 DISEASE RECURRENCE 9 0.0002
604 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
605 SCIATICA 3 0.0002
606 ABSCESS 3 0.0002
607 SURGERY 11 0.0002
608 BREAST PAIN 2 0.0002
609 SENSORY DISTURBANCE 3 0.0002
610 HEREDITARY ANGIOEDEMA 2 0.0002
611 MUSCLE TIGHTNESS 3 0.0002
612 THROAT TIGHTNESS 5 0.0002
613 MUSCULAR WEAKNESS 21 0.0002
614 INSOMNIA 49 0.0002
615 SKIN LACERATION 2 0.0002
616 SEPTIC SHOCK 8 0.0002
617 COVID-19 32 0.0002
618 GASTROINTESTINAL PAIN 2 0.0002
619 HEART RATE INCREASED 18 0.0002
620 VENTRICULAR TACHYCARDIA 3 0.0002
621 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
622 DISCOMFORT 11 0.0002
623 FUNGAL INFECTION 6 0.0002
624 SKIN DISORDER 6 0.0002
625 URINARY RETENTION 6 0.0002
626 COUGH 50 0.0002
627 ANGER 6 0.0002
628 CIRCULATORY COLLAPSE 3 0.0002
629 BLOOD GLUCOSE INCREASED 33 0.0002
630 MICTURITION URGENCY 2 0.0002
631 ATRIAL FIBRILLATION 17 0.0002
632 TINNITUS 8 0.0002
633 SHOCK 4 0.0002
634 MADAROSIS 2 0.0002
635 DECREASED APPETITE 40 0.0002
636 HEART RATE DECREASED 6 0.0002
637 PALPITATIONS 20 0.0002
638 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
639 BLOOD IRON DECREASED 2 0.0002
640 THIRST 3 0.0002
641 BLOOD POTASSIUM DECREASED 5 0.0002
642 PREMATURE BABY 5 0.0002
643 CONSTIPATION 36 0.0002
644 RESTLESS LEGS SYNDROME 3 0.0002
645 NOCTURIA 2 0.0002
646 SCHIZOPHRENIA 2 0.0002
647 URINARY TRACT INFECTION 28 0.0002
648 FEELING ABNORMAL 39 0.0002
649 DYSPEPSIA 16 0.0002
650 SPINAL OPERATION 2 0.0002
651 BRONCHITIS 12 0.0002
652 HYPERCALCAEMIA 2 0.0002
653 ANXIETY 46 0.0002
654 GENERALISED OEDEMA 2 0.0002
655 ILEUS 2 0.0002
656 MIDDLE INSOMNIA 3 0.0002
657 HYPONATRAEMIA 9 0.0002
658 SECRETION DISCHARGE 2 0.0002
659 HALLUCINATION 12 0.0002
660 BLOOD SODIUM DECREASED 3 0.0002
661 ARTHRALGIA 66 0.0002
662 FOOT FRACTURE 3 0.0002
663 MUSCLE SPASMS 29 0.0002
664 MOOD SWINGS 5 0.0002
665 NAUSEA 124 0.0002
666 CHOLESTASIS 3 0.0002
667 THROAT IRRITATION 7 0.0002
668 HERNIA 3 0.0002
669 DIZZINESS 77 0.0002
670 WEIGHT DECREASED 43 0.0002
671 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
672 CHOKING 3 0.0002
673 SWELLING FACE 10 0.0002
674 NODULE 2 0.0002
675 KIDNEY INFECTION 3 0.0002
676 SPEECH DISORDER 8 0.0002
677 TOOTH INFECTION 2 0.0002
678 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
679 STAPHYLOCOCCAL INFECTION 5 0.0002
680 DISORIENTATION 6 0.0002
681 HYPERTENSION 32 0.0002
682 UNDERDOSE 11 0.0002
683 BLOOD PRESSURE DECREASED 10 0.0002
684 CYTOKINE RELEASE SYNDROME 3 0.0001
685 HAIR TEXTURE ABNORMAL 2 0.0001
686 DRY MOUTH 12 0.0001
687 UVEITIS 2 0.0001
688 HEADACHE 92 0.0001
689 GINGIVAL BLEEDING 2 0.0001
690 RASH ERYTHEMATOUS 7 0.0001
691 GAIT DISTURBANCE 28 0.0001
692 OSTEOPOROSIS 6 0.0001
693 MEMORY IMPAIRMENT 20 0.0001
694 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
695 DIVERTICULITIS 4 0.0001
696 PROCEDURAL PAIN 4 0.0001
697 MENTAL STATUS CHANGES 4 0.0001
698 ORAL DISCOMFORT 2 0.0001
699 POLLAKIURIA 6 0.0001
700 DEMENTIA 4 0.0001
701 BURNING SENSATION 10 0.0001
702 VOMITING 67 0.0001
703 DEHYDRATION 19 0.0001
704 DEVICE OCCLUSION 2 0.0001
705 SKIN REACTION 2 0.0001
706 EYE PAIN 8 0.0001
707 OFF LABEL USE 124 0.0001
708 IMPAIRED WORK ABILITY 3 0.0001
709 INTENTIONAL DOSE OMISSION 4 0.0001
710 DRY EYE 7 0.0001
711 POOR QUALITY SLEEP 3 0.0001
712 RHINORRHOEA 9 0.0001
713 IMPAIRED QUALITY OF LIFE 2 0.0001
714 PRURITUS GENERALISED 3 0.0001
715 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
716 ANOSMIA 2 0.0001
717 HYPOKINESIA 2 0.0001
718 FLUID RETENTION 7 0.0001
719 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
720 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
721 APATHY 2 0.0001
722 GASTROENTERITIS 2 0.0001
723 DIARRHOEA 88 0.0001
724 DEPRESSION 31 0.0001
725 MIGRAINE 13 0.0001
726 INFLAMMATION 7 0.0001
727 PRURITUS 52 0.0001
728 PAIN 83 0.0001
729 TACHYCARDIA 12 0.0001
730 SKIN HAEMORRHAGE 2 0.0001
731 FATIGUE 105 0.0001
732 RASH MACULO-PAPULAR 3 0.0001
733 SEPSIS 15 0.0001
734 RASH PAPULAR 3 0.0001
735 SNEEZING 3 0.0001
736 PARAESTHESIA 21 0.0001
737 BONE LOSS 2 0.0001
738 TREATMENT FAILURE 11 0.0001
739 HEART RATE IRREGULAR 3 0.0001
740 DYSPNOEA 75 0.0001
741 MALAISE 58 0.0001
742 ECONOMIC PROBLEM 2 0.0001
743 OSTEOPENIA 2 0.0001
744 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
745 ACIDOSIS 1 0.0001
746 NEPHROLITHIASIS 6 0.0001
747 NASOPHARYNGITIS 24 0.0001
748 SOMNOLENCE 26 0.0001
749 RENAL DISORDER 6 0.0001
750 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
751 APNOEA 1 0.0001
752 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
753 BALANCE DISORDER 11 0.0001
754 CYANOSIS 2 0.0001
755 PRODUCT USE COMPLAINT 2 0.0001
756 TREMOR 21 0.0001
757 HEAD INJURY 4 0.0001
758 ABDOMINAL PAIN UPPER 26 0.0001
759 ULCER 2 0.0001
760 NECK PAIN 7 0.0001
761 INTENTIONAL OVERDOSE 8 0.0001
762 ABDOMINAL PAIN 29 0.0001
763 TOXICITY TO VARIOUS AGENTS 21 0.0001
764 VISION BLURRED 17 0.0001
765 LACTIC ACIDOSIS 4 0.0001
766 PRESYNCOPE 3 0.0001
767 DYSKINESIA 5 0.0001
768 AMNESIA 8 0.0001
769 ALOPECIA 24 0.0001
770 CHOLELITHIASIS 4 0.0001
771 PRODUCT SUBSTITUTION ISSUE 7 0.0001
772 MANIA 2 0.0001
773 ABASIA 3 0.0001
774 CYTOMEGALOVIRUS INFECTION 2 0.0001
775 BONE PAIN 7 0.0001
776 NASAL CONGESTION 7 0.0001
777 EYE PRURITUS 4 0.0001
778 PERICARDITIS 2 0.0001
779 ABDOMINAL PAIN LOWER 3 0.0001
780 FACE OEDEMA 2 0.0001
781 BLOOD PRESSURE INCREASED 18 0.0001
782 HYPOPHAGIA 3 0.0001
783 ERYTHEMA 24 0.0001
784 ANAPHYLACTIC SHOCK 3 0.0001
785 DEAFNESS 3 0.0001
786 SEDATION 3 0.0001
787 HYPOAESTHESIA 17 0.0001
788 PANCREATITIS 6 0.0001
789 EAR INFECTION 3 0.0001
790 EXPOSURE DURING PREGNANCY 7 0.0001
791 CEREBRAL HAEMORRHAGE 4 0.0001
792 GOUT 2 0.0001
793 OSTEOMYELITIS 2 0.0001
794 PERIPHERAL SWELLING 17 0.0001
795 PELVIC PAIN 2 0.0001
796 CRYING 4 0.0001
797 MOOD ALTERED 3 0.0001
798 END STAGE RENAL DISEASE 2 0.0001
799 SKIN LESION 3 0.0001
800 CARDIAC ARREST 9 0.0001
801 PAIN IN EXTREMITY 32 0.0001
802 ANAPHYLACTIC REACTION 6 0.0001
803 OROPHARYNGEAL PAIN 10 0.0001
804 RASH 47 0.0001
805 THINKING ABNORMAL 2 0.0001
806 ABDOMINAL DISCOMFORT 18 0.0001
807 SWELLING 10 0.0001
808 OXYGEN SATURATION DECREASED 6 0.0001
809 HEPATIC CIRRHOSIS 2 0.0001
810 PHOTOPHOBIA 2 0.0001
811 HOT FLUSH 8 0.0001
812 PAIN IN JAW 3 0.0001
813 CONFUSIONAL STATE 17 0.0001
814 DIABETES MELLITUS 8 0.0001
815 SLEEP APNOEA SYNDROME 2 0.0001
816 LETHARGY 6 0.0001
817 PULMONARY FIBROSIS 2 0.0001
818 ASTHENIA 39 0.0001
819 ERUCTATION 2 0.0001
820 PRESCRIBED OVERDOSE 2 0.0001
821 BACK PAIN 24 0.0001
822 DYSSTASIA 3 0.0001
823 SKIN FISSURES 2 0.0001
824 MENORRHAGIA 2 0.0001
825 PSYCHOTIC DISORDER 3 0.0001
826 URTICARIA 17 0.0001
827 URINARY INCONTINENCE 3 0.0001
828 SINUS DISORDER 2 0.0001
829 HAEMATOCRIT DECREASED 2 0.0001
830 UPPER LIMB FRACTURE 2 0.0001
831 RESPIRATORY DISORDER 3 0.0001
832 ADVERSE DRUG REACTION 9 0.0001
833 PREGNANCY 2 0.0001
834 IRRITABILITY 6 0.0001
835 CARDIAC FAILURE CONGESTIVE 8 0.0001
836 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
837 CELLULITIS 5 0.0001
838 SLEEP DISORDER 7 0.0001
839 PRODUCT ADMINISTRATION ERROR 2 0.0001
840 ILL-DEFINED DISORDER 6 0.0001
841 PRODUCT DOSE OMISSION ISSUE 29 0.0001
842 PSORIATIC ARTHROPATHY 4 0.0001
843 SUICIDAL IDEATION 9 0.0001
844 PRODUCT PREPARATION ERROR 2 0.0001
845 LIMB DISCOMFORT 3 0.0001
846 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
847 NERVOUSNESS 5 0.0001
848 HAEMORRHAGE 10 0.0001
849 ROAD TRAFFIC ACCIDENT 4 0.0001
850 WITHDRAWAL SYNDROME 4 0.0001
851 DERMATITIS ATOPIC 5 0.0001
852 DYSPHAGIA 9 0.0001
853 DRUG INTERACTION 15 0.0001
854 HIP FRACTURE 3 0.0001
855 FALL 31 0.0001
856 FAECES DISCOLOURED 2 0.0001
857 EXPIRED PRODUCT ADMINISTERED 3 0.0001
858 OEDEMA PERIPHERAL 11 0.0001
859 LIP SWELLING 3 0.0001
860 ARTHROPATHY 5 0.0001
861 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
862 PANCYTOPENIA 5 0.0001
863 ARTHRITIS 7 0.0001
864 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
865 HERPES ZOSTER 5 0.0001
866 NIGHTMARE 3 0.0001
867 HYPERKALAEMIA 3 0.0001
868 INJURY 6 0.0001
869 DISEASE PROGRESSION 10 0.0001
870 ARRHYTHMIA 4 0.0001
871 MOBILITY DECREASED 6 0.0001
872 LOCALISED INFECTION 2 0.0001
873 MENTAL IMPAIRMENT 2 0.0001
874 DRY SKIN 11 0.0001
875 AGITATION 6 0.0001
876 ENCEPHALOPATHY 2 0.0001
877 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
878 WEIGHT INCREASED 18 0.0001
879 AGEUSIA 2 0.0001
880 PNEUMONIA ASPIRATION 2 0.0001
881 SYNCOPE 8 0.0001
882 AGGRESSION 4 0.0001
883 COLITIS 3 0.0001
884 HAEMATEMESIS 2 0.0001
885 LOSS OF CONSCIOUSNESS 10 0.0001
886 ANOREXIA 1 0.0001
887 SKIN ULCER 2 0.0001
888 HAEMATOMA 2 0.0001
889 EXPOSURE VIA SKIN CONTACT 2 0.0001
890 DEEP VEIN THROMBOSIS 5 0.0001
891 MUSCULOSKELETAL PAIN 4 0.0001
892 HYPERSENSITIVITY 14 0.0001
893 HYPOTENSION 15 0.0001
894 PRODUCT USE ISSUE 14 0.0001
895 FREQUENT BOWEL MOVEMENTS 2 0.0001
896 RASH PRURITIC 4 0.0001
897 LIMB INJURY 2 0.0001
898 INFLUENZA LIKE ILLNESS 6 0.0001
899 CONTUSION 7 0.0001
900 INJECTION SITE REACTION 5 0.0001
901 VISUAL IMPAIRMENT 9 0.0001
902 ABNORMAL DREAMS 2 0.0001
903 ACUTE KIDNEY INJURY 11 0.0001
904 HAEMOPTYSIS 2 0.0001
905 APHONIA 1 0.0001
906 OSTEOARTHRITIS 3 0.0001
907 RECTAL HAEMORRHAGE 3 0.0001
908 HYPERSOMNIA 2 0.0001
909 HYPOACUSIS 3 0.0001
910 EYE IRRITATION 4 0.0001
911 PANCREATIC CARCINOMA 2 0.0001
912 NEEDLE ISSUE 2 0.0001
913 RENAL FAILURE 9 0.0001
914 DYSGEUSIA 5 0.0001
915 PULMONARY OEDEMA 3 0.0001
916 CORONARY ARTERY DISEASE 2 0.0001
917 FEELING HOT 4 0.0001
918 FEMUR FRACTURE 2 0.0001
919 MULTIPLE SCLEROSIS 3 0.0001
920 MOVEMENT DISORDER 2 0.0001
921 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
922 IMPAIRED HEALING 2 0.0001
923 EYE DISORDER 2 0.0001
924 GAIT INABILITY 2 0.0001
925 INJECTION SITE PRURITUS 4 0.0001
926 TYPE 2 DIABETES MELLITUS 2 0.0001
927 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
928 SKIN EXFOLIATION 5 0.0001
929 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
930 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
931 GASTRIC DISORDER 2 0.0001
932 AMENORRHOEA 1 0.0001
933 THERAPY INTERRUPTED 4 0.0001
934 TREATMENT NONCOMPLIANCE 3 0.0001
935 HAEMATOCHEZIA 3 0.0001
936 INFLUENZA 6 0.0001
937 EPISTAXIS 4 0.0001
938 CARDIAC DISORDER 5 0.0001
939 DYSARTHRIA 2 0.0001
940 FLATULENCE 3 0.0001
941 ACNE 4 0.0001
942 PULMONARY EMBOLISM 5 0.0001
943 CONVULSION 3 0.0001
944 INJECTION SITE SWELLING 4 0.0001
945 ACUTE RESPIRATORY FAILURE 1 0.0001
946 DRUG INEFFECTIVE 68 0.0001
947 ABNORMAL BEHAVIOUR 2 0.0001
948 CATARACT 3 0.0001
949 INJECTION SITE BRUISING 4 0.0001
950 PROSTATE CANCER 4 0.0000
951 JOINT SWELLING 6 0.0000
952 THERAPEUTIC RESPONSE DECREASED 3 0.0000
953 DEVICE BREAKAGE 2 0.0000
954 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
955 VAGINAL HAEMORRHAGE 2 0.0000
956 DEVICE DISLOCATION 2 0.0000
957 PRODUCT DOSE OMISSION 3 0.0000
958 INJECTION SITE PAIN 14 0.0000
959 COLITIS ULCERATIVE 2 0.0000
960 DEVICE ISSUE 4 0.0000
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
962 OVERDOSE 9 0.0000
963 CEREBROVASCULAR ACCIDENT 7 0.0000
964 EMOTIONAL DISTRESS 5 0.0000
965 INJECTION SITE ERYTHEMA 5 0.0000
966 UNEVALUABLE EVENT 3 0.0000
967 INCORRECT DOSE ADMINISTERED 9 0.0000
968 HOSPITALISATION 6 0.0000
969 THERAPY CESSATION 2 0.0000
970 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
971 PSORIASIS 5 0.0000
972 APPLICATION SITE ERYTHEMA 1 0.0000
973 ANHEDONIA 1 0.0000
974 DEPRESSED MOOD 2 0.0000
975 BRADYCARDIA 2 0.0000
976 DRUG EFFECT DECREASED 2 0.0000
977 BLISTER 2 0.0000
978 RHEUMATOID ARTHRITIS 4 0.0000
979 ANGINA PECTORIS 1 0.0000
980 PRODUCT STORAGE ERROR 3 0.0000
981 DRUG WITHDRAWAL SYNDROME 3 0.0000
982 ACUTE MYOCARDIAL INFARCTION 1 0.0000
983 ADVERSE EVENT 3 0.0000
984 NEOPLASM MALIGNANT 2 0.0000
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
986 PRODUCT QUALITY ISSUE 4 0.0000
987 DEATH 24 0.0000
988 ACCIDENTAL OVERDOSE 1 0.0000
989 INJECTION SITE HAEMORRHAGE 2 0.0000
990 DRUG DOSE OMISSION 4 0.0000
991 BREAST CANCER 2 0.0000
992 NO ADVERSE EVENT 3 0.0000
993 MYOCARDIAL INFARCTION 2 0.0000